Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

USA - NASDAQ:SLAB - US8269191024 - Common Stock

133.78 USD
-1.74 (-1.28%)
Last: 9/12/2025, 8:17:15 PM
133.78 USD
0 (0%)
After Hours: 9/12/2025, 8:17:15 PM
Fundamental Rating

4

Overall SLAB gets a fundamental rating of 4 out of 10. We evaluated SLAB against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While SLAB has a great health rating, there are worries on its profitability. While showing a medium growth rate, SLAB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLAB has reported negative net income.
In the past year SLAB had a positive cash flow from operations.
In multiple years SLAB reported negative net income over the last 5 years.
In multiple years SLAB reported negative operating cash flow during the last 5 years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

SLAB's Return On Assets of -8.57% is on the low side compared to the rest of the industry. SLAB is outperformed by 71.43% of its industry peers.
With a Return On Equity value of -9.86%, SLAB is not doing good in the industry: 65.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

SLAB has a better Gross Margin (54.95%) than 75.89% of its industry peers.
In the last couple of years the Gross Margin of SLAB has declined.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

More info and screens

8

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLAB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SLAB has been reduced compared to 5 years ago.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SLAB has an Altman-Z score of 18.31. This indicates that SLAB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SLAB (18.31) is better than 87.50% of its industry peers.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.31
ROIC/WACCN/A
WACC11.32%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SLAB has a Current Ratio of 5.12. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SLAB (5.12) is better than 75.89% of its industry peers.
A Quick Ratio of 4.45 indicates that SLAB has no problem at all paying its short term obligations.
SLAB's Quick ratio of 4.45 is fine compared to the rest of the industry. SLAB outperforms 75.89% of its industry peers.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.45
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.76% over the past year.
Looking at the last year, SLAB shows a very strong growth in Revenue. The Revenue has grown by 29.65%.
The Revenue has been growing slightly by 4.28% on average over the past years.
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%

3.2 Future

SLAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.51% yearly.
Based on estimates for the next years, SLAB will show a very strong growth in Revenue. The Revenue will grow by 22.71% on average per year.
EPS Next Y142.86%
EPS Next 2Y86.26%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue Next Year34.83%
Revenue Next 2Y26.68%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLAB. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 52.94 indicates a quite expensive valuation of SLAB.
SLAB's Price/Forward Earnings ratio is in line with the industry average.
SLAB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 52.94
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SLAB is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 58.49
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

SLAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SLAB's earnings are expected to grow with 64.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.26%
EPS Next 3Y64.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILICON LABORATORIES INC

NASDAQ:SLAB (9/12/2025, 8:17:15 PM)

After market: 133.78 0 (0%)

133.78

-1.74 (-1.28%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners106.6%
Inst Owner Change-1.35%
Ins Owners1.88%
Ins Owner Change2.55%
Market Cap4.39B
Analysts74.12
Price Target152.24 (13.8%)
Short Float %5.48%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.72%
Min EPS beat(2)12.85%
Max EPS beat(2)16.59%
EPS beat(4)3
Avg EPS beat(4)16.76%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)6
Avg EPS beat(8)13.41%
EPS beat(12)8
Avg EPS beat(12)11.9%
EPS beat(16)12
Avg EPS beat(16)23.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-1.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.77%
Revenue beat(12)2
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)-0.25%
PT rev (3m)8.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)23.74%
EPS NY rev (1m)13.56%
EPS NY rev (3m)13.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.94
P/S 6.24
P/FCF 58.49
P/OCF 46.32
P/B 4.14
P/tB 6.68
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)2.53
Fwd EY1.89%
FCF(TTM)2.29
FCFY1.71%
OCF(TTM)2.89
OCFY2.16%
SpS21.43
BVpS32.33
TBVpS20.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 10.68%
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 44.06%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.45
Altman-Z 18.31
F-Score6
WACC11.32%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
EPS Next Y142.86%
EPS Next 2Y86.26%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%
Revenue Next Year34.83%
Revenue Next 2Y26.68%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y32.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year163.19%
EBIT Next 3Y64.09%
EBIT Next 5YN/A
FCF growth 1Y563.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y724.28%
OCF growth 3YN/A
OCF growth 5YN/A